WAXMAN STRATEGIES

Lobbying for 340B HEALTH · advocacy and membership organization

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $25,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Issues affecting the 340B drug pricing program, drug prices, and health care costs

Pharmacy

Issues affecting the 340B drug pricing program; Appropriations for 340B program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.